Subscribe to Newsletter

Discovery & Development

Discovery & Development Drug Discovery

Fixing Faulty Splicing

| Stephanie Vine | 2 min read

How antisense oligonucleotides open up targeted approaches to rare disease treatment.

Discovery & Development Formulation

Schizophrenia and the Future of Long-Acting Therapeutics

| Stephanie Vine | 5 min read

Long-acting injectables help with adherence, but what if an unfolding pill could provide an oral option?

Discovery & Development Drug Delivery

The Force Meets Oligonucleotides

| Stephanie Vine

Researchers develop a new platform to improve delivery of oligonucleotide therapies to muscle.

Discovery & Development Clinical Trials

Asking the Right Questions in R&D

| 3 min read

And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.

Discovery & Development Drug Discovery

Rethinking Osteoarthritis With Extracellular Vesicles

| 4 min read

Why researchers are excited about the potential of extracellular vesicles from umbilical cord-derived stem cells.

Discovery & Development Drug Discovery

Breaking Through Rare Diseases

| Stephanie Vine | 8 min read

We asked three rare disease drug developers about their work, the challenges facing the field, and what they would do with unlimited funds.

Discovery & Development Drug Delivery

RIDE: A New Approach to CRISPR Delivery

| Rob Coker | 2 min read

A new study reports targeted CRISPR delivery in retinal and neurological disease models – without viral vectors.

Discovery & Development Clinical Trials

The Role of Data in Drug Development

| Daniel Chancellor | 4 min read

How connecting the data dots can lead to better development and clinical trals. 

Discovery & Development Drug Discovery

Searching for a Lassa Fever Vaccine

| Stephanie Vine | 7 min read

A Lassa fever vaccine candidate shows promise in animal studies, with guinea pigs 100 percent protected from lethal virus exposure.

Discovery & Development Drug Discovery

Characterizing RNA-Based Medicines

| Matthew Lauber, Andrew Argo, Elizabeth Foley | 5 min read

How precision analytics is driving the future of pharmaceuticals, from small molecules to CRISPR gene editing.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker